Related Experiment Videos
[Evidence based treatment of epilepsy]
J A Armijo1, B Sanchez, A B González
1Servicio de Farmacología Clínica. Hospital Universitario Marqués de Valdecilla. Santander, Cantabria, España.
Revista De Neurologia
|October 10, 2002
Summary
Evidence-based medicine aids clinical decisions for epilepsy treatment. However, current research on antiepileptic drugs is limited, necessitating larger comparative trials for better treatment strategies.
Area of Science:
- Neurology
- Evidence-Based Medicine
- Pharmacology
Background:
- Evidence-based medicine (EBM) principles, including systematic reviews and meta-analyses, are increasingly vital for clinical decision-making.
- EBM synthesizes research to guide best practices across medical fields.
Purpose of the Study:
- To review the available evidence-based medicine resources for epilepsy treatment.
- To identify gaps in the current research on antiepileptic drug efficacy and tolerability.
Main Methods:
- Discussion of core EBM concepts: systematic review, meta-analysis, odds ratio, relative risk, and number needed to treat.
- Description of primary, secondary, and tertiary drug information sources, emphasizing EBM repositories like TRIP, DARE, and Cochrane Library.
- Analysis of epilepsy treatment information within clinical practice guidelines, Clinical Evidence, and Bandolier.
Main Results:
- Most clinical trials focus on add-on new antiepileptic drugs for partial refractory epilepsy.
- Limited trials exist for monotherapy, newly diagnosed epilepsy, other epilepsy types, pediatric populations, and direct drug comparisons (new vs. old or new vs. new).
Conclusions:
- Epilepsy treatment currently relies more on clinical expertise and habit than robust trial data.
- There is a critical need for large-scale comparative trials using validated measures for efficacy, quality of life, tolerability, and cognitive function.